 H.RES.681
To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.
 1 Total Points
Summary
Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes. What do you think?
|
Legislation Detail
 Viewed 101 times.
Legislation Slant
Latest Action:
Referred to House subcommittee. Status: Referred to the Subcommittee on Health.
This action occurred on Thursday, November 8, 2007 and earned 1 points.
Legislative Progress
Introduced in the House on September 25, 2007
|
||||||||||||||||||||
|
|
|
